Thompson, P A
Rezvani, K
Hosing, C M
Oran, B
Olson, A L
Popat, U R
Alousi, A M
Shah, N D
Parmar, S
Bollard, C
Hanley, P
Kebriaei, P
Cooper, L
Kellner, J
McNiece, I K
Shpall, E J
Article History
First Online: 3 June 2015
Competing interests
: LC has served as a consultant for Targazyme (formerly American Stem cells), GE Healthcare, Ferring Pharmaceuticals, Fate Therapeutics, Janssen Pharmaceuticals, and Bristol-Myers Squibb. LC owns equity/stock in Targazyme, has received lecture fees from Miltenyi Biotec and served on the Scientific Advisory Board of Cellectis. CMH has received grant support from Celgene. NDS has served on a Celgene Advisory Board and received grant support from Celgene.